NEW YORK, May 10 – Visible Genetics of Toronto said Thursday its first quarter revenues slipped slightly to $3.57 million, compared with $3.64 million in the year ago period, as an increase in product sales failed to offset a sharp drop in revenues from services.

During the quarter, however, the clinical genomics company said sales of its genotyping kits and consumables rose 85 percent from the year ago quarter. The company did not offer a dollar figure for sales of these products.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.